Works by McBain, Catherine


Results: 27
    1

    The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis.

    Published in:
    Neuro-Oncology Advances, 2023, v. 5, p. i94, doi. 10.1093/noajnl/vdac127
    By:
    • Gregory, Grace E.;
    • Islim, Abdurrahman I.;
    • Hannan, Cathal John;
    • Jones, Adam P.;
    • Hammerbeck-Ward, Charlotte;
    • Rutherford, Scott A.;
    • Freeman, Simon R.;
    • Lloyd, Simon;
    • Kalamarides, Michel;
    • Smith, Miriam J.;
    • Couper, Kevin;
    • McBain, Catherine A.;
    • Jenkinson, Michael D.;
    • Brough, David;
    • King, Andrew T.;
    • Evans, D. Gareth;
    • Pathmanaban, Omar N.
    Publication type:
    Article
    2
    3

    Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression.

    Published in:
    Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad025
    By:
    • Evans, D Gareth;
    • Halliday, Dorothy;
    • Obholzer, Rupert;
    • Afridi, Shazia;
    • Forde, Claire;
    • Rutherford, Scott A;
    • Hammerbeck-Ward, Charlotte;
    • Lloyd, Simon K;
    • Freeman, Simon M;
    • Pathmanaban, Omar N;
    • Thomas, Owen M;
    • Laitt, Roger D;
    • Stivaros, Stavros;
    • Kilday, John-Paul;
    • Vassallo, Grace;
    • McBain, Catherine;
    • Lavin, Timothy;
    • Paterson, Chay;
    • Whitfield, Gillian;
    • McCabe, Martin G
    Publication type:
    Article
    4

    A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma.

    Published in:
    2021
    By:
    • Twelves, Chris;
    • Sabel, Michael;
    • Checketts, Daniel;
    • Miller, Sharon;
    • Tayo, Bola;
    • Jove, Maria;
    • Brazil, Lucy;
    • Short, Susan C.;
    • on behalf of the GWCA1208 study group;
    • McBain, Catherine;
    • Haylock, Brian;
    • Mulholland, Paul;
    • Herbert, Christopher;
    • James, Allan;
    • Hingorani, Mohan;
    • Berrouschot, Joerg;
    • Fietkau, Rainer;
    • Panse, Jens;
    • GWCA1208 study group
    Publication type:
    journal article
    5

    Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 1, p. 117, doi. 10.1007/s11060-016-2276-9
    By:
    • Morris, Katrina;
    • Golding, John;
    • Blesing, Claire;
    • Evans, D.;
    • Ferner, Rosalie;
    • Foweraker, Karen;
    • Halliday, Dorothy;
    • Jena, Raj;
    • McBain, Catherine;
    • McCabe, Martin;
    • Swampillai, Angela;
    • Warner, Nicola;
    • Wilson, Shaun;
    • Parry, Allyson;
    • Afridi, Shazia
    Publication type:
    Article
    6

    Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.

    Published in:
    Acta Neuropathologica, 2021, v. 141, n. 6, p. 945, doi. 10.1007/s00401-021-02291-6
    By:
    • Tesileanu, C. Mircea S.;
    • Vallentgoed, Wies R.;
    • Sanson, Marc;
    • Taal, Walter;
    • Clement, Paul M.;
    • Wick, Wolfgang;
    • Brandes, Alba Ariela;
    • Baurain, Jean Francais;
    • Chinot, Olivier L.;
    • Wheeler, Helen;
    • Gill, Sanjeev;
    • Griffin, Matthew;
    • Rogers, Leland;
    • Rudà, Roberta;
    • Weller, Michael;
    • McBain, Catherine;
    • Reijneveld, Jaap;
    • Enting, Roelien H.;
    • Caparrotti, Francesca;
    • Lesimple, Thierry
    Publication type:
    Article
    7

    Glioblastoma and radiotherapy: A multicenter AI study for Survival Predictions from MRI (GRASP study).

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 6, p. 1138, doi. 10.1093/neuonc/noae017
    By:
    • Chelliah, Alysha;
    • Wood, David A;
    • Canas, Liane S;
    • Shuaib, Haris;
    • Currie, Stuart;
    • Fatania, Kavi;
    • Frood, Russell;
    • Rowland-Hill, Chris;
    • Thust, Stefanie;
    • Wastling, Stephen J;
    • Tenant, Sean;
    • McBain, Catherine;
    • Foweraker, Karen;
    • Williams, Matthew;
    • Wang, Qiquan;
    • Roman, Andrei;
    • Dragos, Carmen;
    • MacDonald, Mark;
    • Lau, Yue Hui;
    • Linares, Christian A
    Publication type:
    Article
    8
    9
    10
    11

    Griddient: a microfluidic array to generate reconfigurable gradients on-demand for spatial biology applications.

    Published in:
    Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05282-3
    By:
    • Sanchez-de-Diego, Cristina;
    • Virumbrales-Muñoz, María;
    • Hermes, Brock;
    • Juang, Terry D.;
    • Juang, Duane S.;
    • Riendeau, Jeremiah;
    • Guzman, Emmanuel Contreras;
    • Reed-McBain, Catherine A.;
    • Abizanda-Campo, Sara;
    • Patel, Janmesh;
    • Hess, Nicholas J.;
    • Skala, Melissa C.;
    • Beebe, David J.;
    • Ayuso, Jose M.
    Publication type:
    Article
    12

    European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 37, doi. 10.1093/neuonc/noac196
    By:
    • Hoang-Xuan, Khê;
    • Deckert, Martina;
    • Ferreri, Andrés J M;
    • Furtner, Julia;
    • Perez-Larraya, Jaime Gallego;
    • Henriksson, Roger;
    • Hottinger, Andreas F;
    • Kasenda, Benjamin;
    • Lefranc, Florence;
    • Lossos, Alexander;
    • McBain, Catherine;
    • Preusser, Matthias;
    • Roth, Patrick;
    • Rudà, Roberta;
    • Schlegel, Uwe;
    • Soffietti, Riccardo;
    • Soussain, Carole;
    • Taphoorn, Martin J B;
    • Touitou, Valérie;
    • Weller, Michael
    Publication type:
    Article
    13

    Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 9, p. 1547, doi. 10.1093/neuonc/noab088
    By:
    • Tesileanu, C Mircea S;
    • Bent, Martin J van den;
    • Sanson, Marc;
    • Wick, Wolfgang;
    • Brandes, Alba A;
    • Clement, Paul M;
    • Erridge, Sara C;
    • Vogelbaum, Michael A;
    • Nowak, Anna K;
    • Baurain, Jean F;
    • Mason, Warren P;
    • Wheeler, Helen;
    • Chinot, Olivier L;
    • Gill, Sanjeev;
    • Griffin, Matthew;
    • Rogers, Leland;
    • Taal, Walter;
    • Rudà, Roberta;
    • Weller, Michael;
    • McBain, Catherine
    Publication type:
    Article
    14

    Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 7, p. 1113, doi. 10.1093/neuonc/noaa284
    By:
    • Forde, Claire;
    • King, Andrew T;
    • Rutherford, Scott A;
    • Hammerbeck-Ward, Charlotte;
    • Lloyd, Simon K;
    • Freeman, Simon R;
    • Pathmanaban, Omar N;
    • Stapleton, Emma;
    • Thomas, Owen M;
    • Laitt, Roger D;
    • Stivaros, Stavros;
    • Kilday, John-Paul;
    • Vassallo, Grace;
    • McBain, Catherine;
    • Kerrigan, Simon;
    • Smith, Miriam J;
    • McCabe, Martin G;
    • Harkness, Elaine F;
    • Evans, D Gareth
    Publication type:
    Article
    15

    Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 12, p. 1840, doi. 10.1093/neuonc/noaa104
    By:
    • Hanna, Catherine;
    • Kurian, Kathreena M;
    • Williams, Karin;
    • Watts, Colin;
    • Jackson, Alan;
    • Carruthers, Ross;
    • Strathdee, Karen;
    • Cruickshank, Garth;
    • Dunn, Laurence;
    • Erridge, Sara;
    • Godfrey, Lisa;
    • Jefferies, Sarah;
    • McBain, Catherine;
    • Sleigh, Rebecca;
    • McCormick, Alex;
    • Pittman, Marc;
    • Halford, Sarah;
    • Chalmers, Anthony J
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma.

    Published in:
    PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193694
    By:
    • Yu, Kenny Kwok-Hei;
    • Taylor, Jessica T.;
    • Pathmanaban, Omar N.;
    • Youshani, Amir Saam;
    • Beyit, Deniz;
    • Dutko-Gwozdz, Joanna;
    • Benson, Roderick;
    • Griffiths, Gareth;
    • Peers, Ian;
    • Cueppens, Peter;
    • Telfer, Brian A.;
    • Williams, Kaye J.;
    • McBain, Catherine;
    • Kamaly-Asl, Ian D.;
    • Bigger, Brian W.
    Publication type:
    Article
    22
    23
    24

    Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSG.

    Published in:
    Neuro-Oncology Practice, 2018, v. 5, n. 1, p. 10, doi. 10.1093/nop/npx022
    By:
    • Kurian, Kathreena M.;
    • Jenkinson, Michael D.;
    • Brennan, Paul M.;
    • Grant, Robin;
    • Jefferies, Sarah;
    • Rooney, Alasdair G.;
    • Bulbeck, Helen;
    • Erridge, Sara C.;
    • Mills, Samantha;
    • McBain, Catherine;
    • McCabe, Martin G.;
    • Price, Stephen J.;
    • Marino, Silvia;
    • Moyes, Erica;
    • Qian, Wendy;
    • Waldman, Adam;
    • Vaqas, Babar;
    • Keatley, Debbie;
    • Burchill, Peter;
    • Watts, Colin
    Publication type:
    Article
    25

    A Position Statement on the Utility of Interval Imaging in Standard of Care Brain Tumour Management: Defining the Evidence Gap and Opportunities for Future Research.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.620070
    By:
    • Booth, Thomas C.;
    • Thompson, Gerard;
    • Bulbeck, Helen;
    • Boele, Florien;
    • Buckley, Craig;
    • Cardoso, Jorge;
    • Dos Santos Canas, Liane;
    • Jenkinson, David;
    • Ashkan, Keyoumars;
    • Kreindler, Jack;
    • Huskens, Nicky;
    • Luis, Aysha;
    • McBain, Catherine;
    • Mills, Samantha J.;
    • Modat, Marc;
    • Morley, Nick;
    • Murphy, Caroline;
    • Ourselin, Sebastian;
    • Pennington, Mark;
    • Powell, James
    Publication type:
    Article
    26
    27